Form 4: Columbia Financial Executive Acquires Shares and Holds Stock Options
SEC Form 4 Filing
Oliver Edward Lewis Jr., SEVP & Head of Commercial Banking at Columbia Financial, Inc., reports acquisition of common stock and holdings of stock options.
Summary
- Oliver Edward Lewis Jr., a senior executive at Columbia Financial, Inc. (CLBK), filed a Form 4 detailing changes in beneficial ownership.
- On June 28, 2024, Lewis acquired common stock through a stock-based deferral plan at a price of $14.97 per share, totaling 49.4583 shares.
- Following the reported transaction, Lewis directly owns 24,668 shares of common stock.
- Lewis also indirectly owns shares through various plans including the Stock-Based Deferral Plan (4,340.785 shares), ESOP (5,353 shares), SERP (2,457 shares), SIM (441 shares), Stock Award (715 shares), Stock Award III (14,591 shares), and Stock Award IV (12,672 shares).
- Lewis holds stock options to purchase 17,647 shares at $17, which vested starting July 23, 2020.
- He also holds options to purchase 57,026 shares at $17.86, which are fully vested and exercisable.
- Additional stock options include 11,579 shares at $15.94 vesting from May 1, 2024, and 8,518 shares at $16.49 vesting from March 6, 2025.
- The stock awards vest in installments, with some tied to performance-based criteria.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions.
Positives
- The acquisition of shares by a senior executive could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Comparison to Industry Standards
- Comparing Columbia Financial's executive compensation and equity ownership to peers like OceanFirst Financial Corp. and Investors Bancorp could provide context.
- Analyzing the vesting schedules and performance-based criteria of stock awards against industry norms would be beneficial.
- Benchmarking the option exercise prices and expiration dates against similar financial institutions can offer insights into the attractiveness of the equity incentives.
Stakeholder Impact
- Shareholders may view the executive's stock acquisition as a positive signal.
- Employees participating in the ESOP and other stock-based plans are indirectly affected by the executive's transactions.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Stock Options (right to buy) $ 17 vesting start date |
| 03/22/2022 | Stock Options (right to buy) $ 17.86 grant date |
| 05/01/2024 | Stock Awards III vesting start date |
| 05/01/2024 | Stock Options (right to buy) $ 15.94 vesting start date |
| 06/28/2024 | Date of transaction for common stock acquisition |
| 03/06/2025 | Stock Awards IV vesting start date |
| 03/06/2025 | Stock Options (right to buy) $ 16.49 vesting start date |
| 07/23/2029 | Stock Options (right to buy) $ 17 expiration date |
| 03/22/2031 | Stock Options (right to buy) $ 17.86 expiration date |
| 05/01/2033 | Stock Options (right to buy) $ 15.94 expiration date |
| 03/06/2034 | Stock Options (right to buy) $ 16.49 expiration date |
| 07/02/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.